[TVTX] YoY Quarter Result on 31-Mar-2022 [#Q1]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
05-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -47.31%
YoY- -41.03%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 41,374 56,993 48,487 47,407 47,769 39,570 38,432 1.23%
PBT -135,767 -86,253 -75,919 -53,554 -18,168 -40,576 -18,149 39.80%
Tax 191 78 52 313 -18,976 401 229 -2.97%
NP -136,061 -86,331 -75,971 -53,867 808 -40,977 -18,378 39.56%
Tax Rate - - - - - - - -
Total Cost 177,435 143,324 124,458 101,274 46,961 80,547 56,810 20.88%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -328.86 -151.48 -156.68 -113.63 1.69 -103.56 -47.82 37.86%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -1.76 -1.27 -1.20 -0.96 0.02 -0.99 -0.46 25.03%
EPS Diluted -1.76 -1.27 -1.20 -0.96 0.02 -0.99 -0.46 25.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.